Results 21 to 30 of about 349,758 (166)

The emerging roles of non-coding competing endogenous RNA in hepatocellular carcinoma

Cancer Cell International, 2020
Accumulating evidence has emerged revealing that noncoding RNAs (ncRNAs) play essential roles in the occurrence and development of hepatocellular carcinoma (HCC). However, the complicated regulatory interactions among various ncRNAs in the development of
Gang Xu, Wei-Yu Xu, Yao Xiao, Bao Jin, Shun-Da Du, Yi-lei Mao, Zhong-Tao Zhang   +6 more
doaj   +1 more source

CHSY1 promotes CD8+ T cell exhaustion through activation of succinate metabolism pathway leading to colorectal cancer liver metastasis based on CRISPR/Cas9 screening

Journal of Experimental & Clinical Cancer Research, 2023
Background The most common site of metastasis in colorectal cancer (CRC) is the liver and liver metastases occur in more than 50% of patients during diagnosis or treatment.
Guangshun Sun, Siqi Zhao, Zhongguo Fan, Yuliang Wang, Hanyuan Liu, Hengsong Cao, Guoqiang Sun, Tian Huang, Hongzhou Cai, Hong Pan, Dawei Rong, Yun Gao, Weiwei Tang   +12 more
doaj   +1 more source

Examination of the characteristics of long-term survivors among patients with gallbladder cancer with liver metastasis who underwent surgical treatment: a retrospective multicenter study (ACRoS1406)

BMC Gastroenterology, 2022
Background Gallbladder cancer (GBC) with liver metastasis is considered unresectable. However, there have been infrequent reports of long-term survival in patients with GBC and liver metastases.
Ryota Higuchi, Hiroaki Ono, Ryusei Matsuyama, Yusuke Takemura, Shinjiro Kobayashi, Takehito Otsubo, Yuta Abe, Itaru Endo, Minoru Tanabe, Masakazu Yamamoto, Association for Clinical Research on Surgery Group (ACRoS1406)   +10 more
doaj   +1 more source

Risk factors and prognosis of liver metastasis in gallbladder cancer patients: A SEER-based study

Frontiers in Surgery, 2022
BackgroundLiver metastasis is a common complication in gallbladder cancer (GBC). We design this study to develop models for predicting the development of liver metastasis in GBC patients and evaluate the risk of mortality in these patients with liver ...
Cheng Fang, Wenhui Li, Qingqiang Wang, Ruoran Wang, Hui Dong, Junjie Chen, Yong Chen   +6 more
doaj   +1 more source

Risk Factors of Early Liver Metastasis for Pancreatic Ductal Adenocarcinoma after Radical Resection

Gastroenterology Research and Practice, 2022
Background. Liver metastasis arises in many postoperative patients with PDAC, occurring in the early stage appears to lead to a very poor prognosis. Objective.
Jingshu Tong, Shengdong Wu, Changjiang Lu, Yong Yang, Shuqi Mao, Caide Lu   +5 more
doaj   +1 more source

Laparoscopic liver resection for liver metastasis of leiomyosarcoma of the thigh: a case report

Surgical Case Reports, 2022
Background Although there is no established treatment strategy for liver metastasis of leiomyosarcoma, liver resection has been reported to be effective in some cases.
Shoichi Tsuzaka, Yoh Asahi, Toshiya Kamiyama, Tatsuhiko Kakisaka, Tatsuya Orimo, Akihisa Nagatsu, Takeshi Aiyama, Takeyuki Uebayashi, Hirofumi Kamachi, Masatake Matsuoka, Kento Wakabayashi, Takuya Otsuka, Yoshihiro Matsuno, Akinobu Taketomi   +13 more
doaj   +1 more source

A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma

Frontiers in Oncology, 2019
Background: Pancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive solid malignant tumors worldwide. Increasing investigations demonstrate that long non-coding RNAs (lncRNAs) expression is abnormally dysregulated in cancers.
Chenhao Zhou, Shun Wang, Qiang Zhou, Jin Zhao, Xianghou Xia, Wanyong Chen, Wanyong Chen, Yan Zheng, Min Xue, Feng Yang, Deliang Fu, Yirui Yin, Manar Atyah, Lunxiu Qin, Lunxiu Qin, Yue Zhao, Christiane Bruns, Huliang Jia, Ning Ren, Ning Ren, Qiongzhu Dong, Qiongzhu Dong   +21 more
doaj   +1 more source

The Impact of Liver Metastasis on Anti-PD-1 Monoclonal Antibody Monotherapy in Advanced Melanoma: Analysis of Five Clinical Studies

Frontiers in Oncology, 2020
Anti-programmed cell death protein 1 (PD-1) monoclonal antibody therapy is becoming a standard treatment for advanced melanoma that produces durable responses and prolonged survival, but the prognosis of patients with liver metastases is still ...
Xuan Wang, Qing Ji, Xieqiao Yan, Bin Lian, Lu Si, Zhihong Chi, Xinan Sheng, Yan Kong, Lili Mao, Xue Bai, Bixia Tang, Siming Li, Li Zhou, Chuanliang Cui, Jun Guo   +14 more
doaj   +1 more source

Diet-Induced Obesity Promotes Liver Metastasis of Pancreatic Ductal Adenocarcinoma via CX3CL1/CX3CR1 Axis

Journal of Immunology Research, 2022
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive cancers, and the patients are generally diagnosed with distant metastasis. Liver is one of the preferred organs of distant metastasis, and liver metastasis is the leading cause of ...
Yue Sun, Xiao-Xin Zhang, Shan Huang, Hong Pan, Yan-Zhi Gai, Yao-Qi Zhou, Lei Zhu, Hui-Zhen Nie, Dong-Xue Li   +8 more
doaj   +1 more source

Liver metastasis mimicking an abscess

BJR|case reports, 2021
Hepatic metastases from carcinoid tumours are typically solid, hypervascular lesions on imaging. The cystic form, mimicking an abscess, is extremely rare. We report a case of a 48-year-old female presenting with a large hepatic mass that was diagnosed as a hepatic abscess, but the ultrasound-guided biopsy showed well-differentiated grade 1 ...
Kaoutar Imrani, Tlaite Oubaddi, Hounayda Jerguigue, Rachida Latib, Youssef Omor   +4 more
openaire   +2 more sources